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Summary
During derivation of transgenic mouse strains with various TL and TL/H-2 chimeric genes,
one strain, TgTle-3-1, introduced with a TL gene (Tla'-3), was found to have an abnormal
thymic T cell population and to develop a high incidence of T cell lymphomas. To investigate
the etiology of the thymic abnormalities and of the lymphomas, the development of lymphoid
organs in transgenic mice was studied . The thymus of these mice goes through three unusual
successive events : perturbation of thymic development during embryogenesis, disappearance of
thymocytes between day 14 and day 21 after birth, and subsequent proliferation oflarge blast-like
cells. These events are associated with the abolishment of T cell receptor (TCR) of lineage
of the T cell differentiation, leading to preponderance of cells belonging to the TCR yS
L3T4 -Lyt-2 - double negative (DN) lineage . Bone marrow transplantation and thymic graft
experiments demonstrate that the abnormality resides in the bone marrow stem cells rather than
in the thymic environment . The expression ofTL antigen in the transgenic mice is greatly increased
and TL is expressed in a wide range ofT cells, including normally TL - DN cells and L3T4+
Lyt-2 - and L3T4 - Lyt-2+ single positive cells. These quantitative and qualitative abnormalities
in TL expression most likely cause the abnormal T cell differentiation .
TheySDN cells migrate into peripheral lymphoid organs and constitute nearly50% ofperipheral
T cells. Immune function ofthe transgenic mice is severely impaired, asT cell function is defective
in antibody production to sheep red blood cells, in mixed lymphocyte culture reaction to allogenic
spleen cells and also in stimulation with concanavalin A . These results indicate that the yS cells
are incapable of participating in these reactions.
Molecular and serological analysis ofT cell lymphomas reveal that they belong to the -yb lineage,
suggesting that the ybDN cells in this strain are susceptible to leukemic transformation . Based
on cell surface phenotype and TCR expression of the DN thymocytes and T cell lymphomas,
a map of the sequential steps involved in the differentiation of ySDN cells is proposed . Tg.Tla'-
3-1 mice should be useful in defining the role ofTL in normal and abnormal T cell differentiation
as well as in the development of T cell lymphomas, and further they should facilitate studies
on the differentiation and function of yS T cells.
M
ouseTL antigens belong to the family ofMHC class I
antigens . However, the expression of TL is distinct
from otherMHC class I antigens, being restricted to normal
thymocytes and T cell lymphomas. Not all strains of mice
express TL in the normal thymus, but even in such TL -
strains an anomalous TL expression is found on T cell lym-
I Abbmviations used in thispaper. B6, C57BL/6; DN, L3T4- Lyt-2- double
negative ; DP, L3T4 + Lyt-2+ double positive; HSA, heat-stable antigen ;
PFC, plaque-forming cell ; Pgp-1, phagocytic glycoprotein 1; SP, L3T4 +
Lyt-2 - or L3T4-Lyt-2 + single positive .
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phomas (1, 2) . To understand the structural basis for TL ex-
pression, we and others have isolated and characterized TL
genes (3-6), and also analyzedTL expression in vitro by trans-
fecting TL and TL/H-2 chimeric genes into L cells (7) . These
studies showed that TL genes resemble other MHC class I
genes in their overall structure but have unique 5' regulatory
elements . To investigate this further, we have recently de-
rived several transgenic mouse strains in C3H/He (TL - )
background with two TL genes, Tla°-3 isolated from the
A-strain mouse (Tla', TL+), and T3b from TL+ leukemia
arising in a C57BL/6 (B6) 1 mouse (Tlab, TL - ), and with
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Volume 174 August 1991 351-362two TL/H-2 chimeric genes (8) . Analysis of the transgene
expression showed that even TL - thymocytes ofOH/He
provide conditions for the transcriptional activation of Tla'-3,
and that Tla'-3 contains necessary elements for correct tis-
sue-specific expression in normal thymocytes, whereas Tab
and the endogenous TL genes of C3H/He lack these ele-
ments . During the course of the study, we found that one
of the transgenic mouse strains, TgXla°-3-1, expresses large
amounts ofTL antigen in thymocytes, and has a small thymus
consisting mainly of L3T4 (CD4) -Lyt-2 (CD8)- double
negative (DN) cells. Furthermore, this strain develops a high
incidence of lymphoid neoplasms.
The differentiation pathway of T cells bearing oiO TCR
in the thymus has been extensively studied, and it has been
conclusively demonstrated that the interaction between a/3
TCR andMHC antigens plays a critical role in the develop-
ment ofthymicT cells (for review, see references 9-12) . The
maturation of cig cells in the thymus has been staged using
various cell surface markers (13, 14) . The differentiation
pathway ofthe other lineage, 76 cells, has also been vigorously
investigated, and many aspects ofyb cells, including func-
tion, localization ofdifferent subsets, thymic selection ofcertain
subsets and putative ligands, have been reported (for review,
see references 15-18) . yb cells, particularly those localized
in epithelial structures, are speculated to function in the pri-
mary defense of the body against infection and other insults
(19) . However, because of the limited number of y6 cells in
lymphoid organs (20-22), analysis oftheir function and staging
of their developmental pathway have been difficult .
In the present study, we have investigated the development
of the immune system in TgXla'-3-1 mice to elucidate the
role ofthe transgene in abnormal thymic differentiation. We
found that T cell differentiation in the transgenic mice is forced
to deviate to the yb lineage through at least three unusual
events in the thymus and that consequently yb cells become
abundant rather than a/3 cells. To delineate the function and
the maturation steps involved in the differentiation ofyb cells,
we characterize DN thymocytes, yb T cell lymphomas and
immune responses of Tg.Tla'-3-1 mice.
Materials and Methods
Mice .
￿
Derivation of the TL transgenic mouse strain, TgTla'-
3-1, has been described elsewhere (8) . Briefly, a DNA fragment
containing Tla'-3 isolated from an A-strain genomic library was
injected into male pronuclei of fertilized eggs ofC3H/He mice
(TL- , Tiab) (8, 23) . The founder mouse of the TgTla'-3-1 strain
contained seven copies of Tla'-3 transgenes in a single chro-
mosomal site. The offspring ofthe founder were interbred to pro-
duce homozygous stock, which then maintained by brother-sister
mating. C3H/He mice were purchased from Japan SLC Inc .
(Hamamatsu, Japan), and other mice were from our breeding colony
or from the National Institute of Genetics (Mishima, Japan) .
Histology.
￿
Tissues were fixed with Bouin's solution and 5 Am
sections were stained with hematoxyline-eosin .
Serological Analysis.
￿
Two-color analysis of cell surface antigens
was performed with a fluorescence-activated cell sorter (FACstar ;
Becton Dickinson and Co ., Mountain View, CA) using mAbs to
TL (HD168, reference 3), L3T4 (GK1.5, reference 24), Lyt-2 (53-7,
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reference 25), TCRaO (H57-597, reference 26), TCR-y6 (3A10,
reference 22), CD3 (145-2C11, reference 27), heat-stable antigen
(HSA) (111d, reference 28), phagocytic glycoprotein 1(Pgp-1, Ly24)
(NU5-50 ; provided by Dr.E. Nakayama, Nagasaki Univ., Nagasaki,
Japan), IL2 receptor a chain (IL2Ra) (7D4, reference 29), and
Thy-1.1 and Thy-1.2 (purchased from Beckton Dickinson andCo.) .
Most antibodies were directly conjugated with fluorescein orbiotin .
The secondary reagents, PE streptavidin (Biomeda, Foster City,
CA), FITC-labeled anti-hamster Ig (Caltag, South San Francisco,
CA), anti-rat Ig (Tago Inc., Burlingame, CA) or anti-mouse Ig
(DAKO, Glostrup, Denmark) were used as appropriate.
Bone Marrow Transplantation and Thymic Graft.
￿
Recipient mice
were lethally irradiated (10 Gy, Hitachi MBR1520R; Hitachi,
Tokyo, Japan) and 1 d later injected intravenously with 10' bone
marrow cells from donor mice . After a few weeks, the lymphoid
system ofthe mice was totally reconstituted by cells of the donor
origin as determined by the expression ofcell surface antigens (Thy-
1.1 or Thy-1.2, and TL+ or TL-) of the donor origin . For the
thymic graft, a lobeof thymus was inserted under the renal capsule
of the host mice . The lymphoid cells in the grafted thymus were
gradually replaced by cells of host origin, which was monitored
by the analysis ofcell surface antigens as in thebone marrow trans-
plantation experiments.
Immune Response
￿
(A) Plaque forming cell (PFC) assay: 108
SRBC were injected intravenously into the transgenic or control
mice . 1 wk later, 106 spleen cells of the immunized mice were
mixed with 2 x 108 SRBC and incubated for 2 h at 37°C in
agarose in the presence of guinea pig complement . The number
ofplaques producing IgM antibody to SRBC was counted (direct
assay), and the number of plaques producing IgG and IgM anti-
bodies was counted by addition of anti-mouse Ig (indirect assay) .
(B) MLC: 106 spleen cells of the transgenic or C3H/He mouse
were mixed with irradiated (24 Gy, HitachiMBR1520R; Hitachi)
spleen cells of BALB/c or B6 and incubated for 4 d at 37°C, fol-
lowed by a 6-h incubation in the presence of 18.5 kBq [3H]thymi-
dine . Cells were harvested on a filter byLABO MASH (Labo Science
Inc., Tokyo, Japan) and precipitated with TCA . The amount of
['H]thymidine in the precipitates was counted with a scintillation
counter (Beckman Instruments, Palo Alto, CA) . (C) Con A stim-
ulation . Total spleen cells or theT cell fraction of spleen purified
by a T cell recovery column kit (Biotex, Alberta, Canada) were
incubated in the presence of 2 hg/ml Con A for 3 d, followed by
a 6-h incubation with the addition of 18.5 kBq ['H]thymidine.
The uptake of [3H]thymidine was measured as in theMLC eacperi-
ments . (D) LPS stimulation . The experimental procedure was es-
sentially the same as the Con A stimulation, except that 20 Fig/ml
LPS (Sigma Chemical Co., St . Louis, MO) was added instead of
Con A .
DNA and RNA Blot Analysis.
￿
Probes for Southern (30) and
Northern (31) blot analyses were prepared either by nick-translation
(32) orby the random priming method (33). TheDNA rearrange-
ment andRNA transcriptswere analyzed with the following probes :
TCR a with pcla (34), TCR a with PL5 (provided by Dr.
D. Y. Loh, Washington Univ., St . Louis, MO), TCR 7 with p8/
10-2711(35), TCR 6 with RAD11C (36), and TL with pnl (3) .
Conditions for hybridization and washing were described previ-
ously (3, 5) .
Results
Abnormal Growth of the Thymus in Tg.Tla°-3-I Transgenic
Mice.
￿
The growth of the thymus in TgTla'-3-1 mice was108
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Change in cell number in thymus, spleen and lymph nodes
during maturation. Open symbols are the results of transgenic mice and
closed symbols are those ofC3H/He mice. Forcounting the cells in lymph
nodes, axillary, brachial, inguinal, and mesenteric nodes were combined.
The mean cell number was calculated from data of at least three virgin
female mice. The data for C3H/He mice are consistent with published
results (37). Thymus and lymph nodes of TgTla--3-1 consistently con-
tain fewer cells than those of age-matched C3H/He mice . The low cell
number ofnewborn thymus, sudden disappearance ofthymocytes between
day 14 and day 21, and gradual increase in the number of thymorytes after
day 35 are characteristic of the transgenic mice.
Changesin the weight ofthe lymphoid organs correlatewellwith those
in the cell number. The weight of the thymus of transgenic mice starts
from 3 .9 ± 0.3 mg at day 0, increase to 21.1 t 2.7 mg at day 14, then
reduces to 13 .6 ± 2 .5 mg at day 21 and recovers to 21.9 ± 6.2 mg at
day 190 . In C3H/He mice, the weight of the thymus is 4.8 t 0.3 mg
at day 0, 57.8 t 6.9 mg at day 14, 64 .1 ± 2.3 mg at day 21 and 36.9
± 4.4 mg at day 190 . The weight of lymph nodes of transgenic mice
is consistently smaller than the control ; 13.7 ± 2.5 mg versus 24.8 ±
2.5 mg at day 14 and 69.1 ± 11.5 mg versus 92.2 ± 16.2mg at day 190 .
Spleen weight or total body weight do not differ significantly between
the transgenic and the control mice throughout the observation period .
assessed by changes in weight, cell number and histology,
and was compared with that of the control C3H/He mice
(Fig. 1 and Fig. 2) . Three unusual events were found to occur
during the development of the transgenic thymus. First, at
birth, the thymus of the transgenicmouse is already smaller
and contains fewer cells than the control . The thymus has
a thin cortex layer and the boundary of cortex and medulla
is not as distinct as in control mice. Second and most strik-
ingly, lymphoid cells abruptly disappear from the transgenic
thymus between day 14 and day 21; the thymus loses 50%
of its weight and 85% of its lymphoid cell population. Con-
sequently, the thymus of 21-d and also 35-d mice has only
a few percent of the thymorytes present in the control thymus.
The thymus at day 21 lacks small lymphocytes in the cortex,
and the distinction between cortex and medulla becomes am-
biguous. Third, uniformly large blast-like cells with high mi-
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totic activity repopulate and occupy the thymus of 35-d or
older mice. With increase in this cell population, both thymus
weight and cell number show partial recovery.
Abnormal Thymic T Cell Differentiation.
￿
Asshown in Fig.
3, the antigenic profile of thymocytes of TgTla'-3-1 mice
also undergoes drastic changes, in parallel with the growth
of the thymus described above. The thymus at each age (be-
fore day 14, at day 21 and after day 35) shows a distinct and
abnormal representation of the four T cell subpopulations
belonging to the different maturation stages, the least ma-
ture L3T4- Lyt-2' DN, the immature L3T4+Lyt-2' double
positive (DP) and the mature L3T4+Lyt-2- or L3T4-Lyt-
2+ single positive (SP) cells. Thy-1 expression by the thymic
cell population indicates their T cell origin . Until day 14,
the thymus has a T cell profile similar to the control, but
it contains an expanded population of DN cells and a rela-
tively small population of DP cells . The sudden disappear-
ance ofcells from the transgenic thymus between day 14 and
day 21 involves 90% ofDP thymocytes as well as 85% of
DN thymocytes. As a result, the thymus of day 21 mice has
all four subpopulations in equal proportion . At day 35, DN
cells become the major population, with 90% of thymocytes
being DN and the remaining 10% Lyt-2+ SP cells, while
DP and L3T4+ SP cells become undetectable. This ab-
normal phenotype becomes stable after day 35, indicating
that the differentiation pathway fromDN to DP thymocytes
has been lost, while theDN pathway remains active. As cal-
culated from Fig. 1 and 3, the number ofDP cells in trans-
genic thymus is <10 5 after day 35, while the control thymus
contains 1.5 x 108 DP cells at day 35 and 9 x 107 at day
70. In contrast, thenumber ofDN thymocytes increases after
day 21 and the thymus at day 70 contains 8 x 106 DN
thymocytes, twice as many as the age-matched control .
Studies ofTCR expression show that DN cells in day 70
thymus express TCR yb (Fig . 3, Row 4) . However, this com-
mitment ofDN cells to TCR yb becomes evident only at
day 35, as the majority of DN cells are negative for TCR
-yb expression before day 21 . The differentiation pathway to
TCR aR+ SP cells is disturbed in the transgenic thymus
(Fig. 3, Row 3), since there are very few TCR a#+L3T4+
SP cells in 35-d or older mice. TCR cxd expression is de-
tected on the relatively expanded SP thymocytes in day 21
mice and on Lyt-2+ SP thymorytes in older mice. TCR cx6
and yb expression is always accompanied by CD3 expression
(Fig. 3, Row 5), suggesting that both TCR a(3 and yb on
the cell surface are functional .
A variable proportion of theDN thymorytes ofyoung trans-
genic mice expresses I1r2 receptor ot chain (IIr2Ra), HSA,
and Pgp-1 . For example, of the DN thymocytes of day 21
mice, 69% are IL2Ra+, 30% HSA+ and 16% Pgp-1+ .
TheDN cells of the control thymus are consistently hetero-
geneous in terms of the expression of these antigens. How-
ever, TCR yb+ DN thymocytes of 70-d-old transgenic mice
become homogeneously negative for these antigens (data not
shown) .
T Cell Receptor (7CR) y6+ Double Negative (DN) TCells
in Peripheral Lymphoid Organs. Lymph nodes of TgTla'-3-1
are consistently smaller in size and contain fewer cells than354
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Figure 3.
￿
Surface antigenic profile of thymocytes . Thymocytes of Tg.Tla-3-1, C3H/He andB6-Tla' were examined by two-colorFACS analysis using
various combinations of mAbs. To identify DN cells easily, a mixture of L3T4 and Lyt-2 antibodies was used in certain experiments; both DP and
SP cells were positive with the mixture whereasDN cells were negative. The percentage of each population is shown in the four comers of each
panel. The antigen profiles ofday 3 and 7thymocytes of transgenic mice were essentially identical to that of day 14 and are not shown in the figure .
As the profile of C3H/He and B6Tla, remained consistent with ages, only those of 21-d-old mice are shown in the figure. TheT cell population
in C3H/He andB6Tla' thymus was comparable with published results (13, 14): 80-85% of thymocytes are DP cells, 3-9% L3T4+ SP cells, 3-6%
Lyt-2+ SP cells, and 3-5% DN cells.
those of C3H/He mice (Fig. 1), with only one fifth to one
half the numbers ofT cells (data not shown) . The spleen
of transgenic mice does not differ significantly in weight or
in cell number from age-matchedcontrols,butcontains about
onehalf oftheT cellspresent in control mice (14.1 ± 1.3%
355
￿
Obata et al .
10 102 103
Day 70
10 102 103
C3H/He
Day 21
93
6
0
77
4 0
0
TCR-yb
CD3
B6-Tlaa
Day 21
3 86
8
TCRa#
86
I
10 102 103
versus 28.3 ± 1.5% Thy-1+ spleen T cells, data not
shown) . Spleen and lymph nodes of Tg.Tlaa-3-1 showed no
obvious histological abnormality, but the white pulp in the
lymph nodes and spleen of TgXla'-3-1 is smaller than in the
control (data not shown) .
Figure 2 .
￿
Histology of Tg.Tla°-3-1 thymus. The thymus of TgTla°-3-1 maintains its basic structure up to day 14 (only the pictures of day 0 and
day 14 thymus are shown) . The distinction between cortex and medulla is clear, and typical thymocytes, small lymphocytes with basophilic nuclei
and little cytoplasm, are relatively abundant in the cortex. However, the cortical area is smaller in the thymus of transgenic mice than in the control
thymus. In day 21 thymus, the demarcation between cortex and medulla becomes unclear, and very few small lymphocytes are found in the cortex .
Most remaining cells have vesicular nuclei and large cytoplasm . In the thymus of day 70, the distinction between cortex and medulla is barely visible,
and the cortex is repopulated with large lymphocytes with less basophilic nuclei and large cytoplasm . Mitotic figures are often observed in these cells.
In C3H/He thymus from day 0 to day 70, the demarcation of cortex and medulla is always clear, and the cortex is filled with typical thymocytes
(the pictures of day 0 and day 70 are shown) . Magnification is 25-fold in the left column and 260-fold in the right column.
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Figure 4 . Thymic population of bone marrow chimera between
Tg.Tla,-3-1 and AKR mice. Lethally irradiated AKR mice were trans-
planted with bone marrow cells of 90-d-old TgTlaa-3-1 mice, and the
thymocytes were analyzed 28 d later. Thymocytes from AKR and TgTlaa-
3-1 of comparable age were tested as controls . The difference in Thy-1
allo-specificity between AKR (Thy-1.1) and TgTla-3-1 (Thy-1 .2) enabled
the origin of Thmocytes to be determined. TL expression also distinguishes
the host (AKR, TL- ) and the donor (TgTlaa-3 .1, TL -1) . Almost all
thymocytes of the chimeric mice have the phenotype of Thy-1 .1- Thy-
1.2'TL+, indicating that they are derived from TgTlaa-3-1 bone marrow
cells. The thymic population in chimeric mice is almost identical to that
of transgenic mice, except for the absence of Lyt-2+ SP cells in the chi-
meric thymus.
The antigenic profile of T cells in peripheral nodes also
undergoes changes characteristic of TgTlaa-3-1 mice (data
not shown) . At day 21, the T cell population in the lymph
nodes of transgenic mice is similar to that in control mice
except the expression ofTL ; 95% ofT cells are TCR czO+
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CD3+TL+ SP cells and only 5% are TCR -yb+CD3+ TL'
DN cells . However, as transgenic mice age, the proportion
of TCR yS+CD3+TL+ DN cells gradually increases, oc-
cupying30% at day 70 and reaching nearly 50% at day 190 .
These results indicate that lymph nodes are first populated
by TCR «R+ SP cells prior to day 21, and then by increas-
ing numbers of TCR yS+ DN cells after day 21.
Expression ofthe Transgene in TgX1aQ-3-1 Thymus.
￿
TL an-
tigen, the product of the Tlaa-3 transgene, is expressed in
Tg.Tlaa-3-1 thymus in a much larger quantity (about 10
times) than in the thymus of any inbred TL+ strain, in-
cluding the A-strain from which the transgene was isolated
(see reference 8) . Further, TL antigen is detected in almost
all thymic T cells of Tg.Tlaa-3-1, including DN and SP cells,
although a fraction of DN cells in younger mice is TL -
(Fig . 3, Row 2) . The proportion ofTL+ DP cells decreases
with aging, while TL+ DN cells increase and become the
major population of the thymus. In B6Tlaa, only DP
thymocytes express TL antigens, whileDN and SP thymo-
cytes are TL- . TL antigen is expressed in almost all T cells
in the lymph nodes of transgenic mice, includingTCR yS+
DN and TCR aa+ SP cells . This contrasts with the situa-
tion in other TL+ mouse strains, where peripheral T cells
do not express TL antigen .
T Cell Abnormality Resides in Bone Marrow Stem Cells.
￿
To
determine whether stem cells derived from the bone marrow
or the thymic environment of TgTlaa-3-1 are responsible for
the abnormal differentiation of T cells, bone marrow trans-
plantation and thymus grafting were carried out. The thymus
ofAKR mice (Thy-1.1+TL - ) reconstituted with bone mar-
row cells oftransgenic mice showed the characteristics of the
transgenic thymus ; the majority of thymocytes were large
blast-like cells and the cortex-medulla distinction was unclear
(data not shown) . The thymocytes of chimeric mice were
entirely replaced by Thy-1.2+TL+ cells of donor origin, and
the major population was TCR yS+ DN cells (Fig. 4) .
Results from the reciprocal combination could not be ob-
tained, because TgTlaa-3-1 recipients ofAKR bone marrow
cells did not survive. However, chimeric TgTlaa-3-1 mice
receiving OH/He bone marrow were produced and were
found to have normal thymic morphology and a normal popu-
lation of thymic T cells (data not shown) . These results indi-
cate that bone marrow stem cells rather than the thymic en-
vironment (including thymic epithelial cells) cause the
abnormal thymic differentiation of TgTlaa-3-1 mice . This
conclusion is confirmed by experiments involving reciprocal
thymic graft . OH/He thymus transplanted under the cap-
sule ofTg.Tlaa-3-1 kidney takes on the characteristics of the
transgenic thymus. 5 wk after the grafting, the thymus be-
comes smaller with no clear cortex-medulla distinction and
is constituted mainly of large lymphoid cells with a
TL+TCR yb+ DN phenotype. In contrast, TgTlaa-3-1
thymus transplanted into C3H/He mice show normal T cell
population and morphology (data not shown) .
Deficient T Cell Immune Function in Tg.Tlaa-3-1 Mice.
TgXlaa-3-1 mice of day 70 or older were examined for their
immune capacity in four different assays. In PFC assays in
the response to SRBC, Tg.Tlaa-3-1 mice yielded fewer IgM-too
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Immune responses of TgTla-3-1 mice . In all assays, 70-d or
older mice were used. In all panels, open circles represent results with
transgenic mice and closed circles with control C3H/He mice. (A) PFC
response to SRBC . The mice were immunizedwith SRBC, and the number
of PFCs in the spleen was enumerated by direct assay for cells producing
IgM antibody and by indirect assay for cells producing IgG and IgM anti-
bodies. TgTla-3-1 had consistently fewer PFCs in both assays. (B) Prolifer-
ative response to allogenic spleen cells in MLC . The transgenic and con-
trol spleen cells were cocultured with irradiated spleen cells of BALB/c
or B6, both of which have different MHC class I and class II antigens
from the transgenic and C3H/He mice . [ 3H]thymidine uptake by the
spleen cells ofthe transgenicmicewas less than the control MLC reactions
with both BALB/c and B6 . (C) Proliferative response to Con A . Unfrac-
tionated spleen cells or purified splenic T cell fraction were cultured in
the presence ofConA . Unfractionated spleen cells and splenic T cell frac-
tion of the transgenic mice were less reactive than the controls.
and IgGproducing cells than the control, as shown in Fig. 5A .
In vitro proliferative responses in MLC against allogenic
BALB/c and B6 spleen cells showed that the transgenic mice
were less reactive than the control (Fig. 5 B) . Similarly, in
the mitogenic response to Con A, transgenic spleen cells were
less efficiently stimulated (Fig. 5 C) . As the spleens of trans-
genic mice contain one half the T cells present in control
spleens (see above), the same number ofT cells isolated from
Tg.Tlaa-3-1 and C3H/He spleens were compared in their re-
sponse toCon A. The results indicate that the T cells oftrans-
genic mice are less reactive than those of the control . In con-
trast to theseT cell dependent assays, the proliferative response
oftransgenic spleen cells to LPS was normal (data not shown) .
These results indicate that T cell function of TgTla'-3-1
mice is impaired, whereas B cell function is not .
Development ofT Cell Lymphomas in Tg.Tlaa-3-1 .
￿
TgTla'-
3-1 mice of 8-15 mo-old often developed enlargement ofspleen
and lymph nodes . Liver, lung and kidney were frequently
involved, while overt enlargement of the thymus was rare.
The infiltrating cells were larger than normal lymphocytes,
with more vesicular nuclei and with relatively abundant
cytoplasm . The gross and microscopic characteristics were
similar in all cases, and these neoplasms could be classified
as "lymphocytic leukemia" according to Dunn (38) . The in-
cidence was over 60%D (32/51 mice) and the tumors were
transplantable inC3H/He mice. C3H/He, used for the deri-
vation of the transgenic strain, has a low incidence of lym-
phocytic leukemia (39) .
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Figure 6 . Surface antigenic profile of TgTla'-3-1 lymphocytic leu-
kemias . Two-color analysis of cell surface antigens of tumor cells was car-
ried out as describedin thelegend to Fig. 3 . The results with three tumors
are illustrated in this figure. All three are Thy-1+TL+Lyt-2 - L3T4- ; two
(C2 and D20) are TCR y6*CD3', while one (El) isTCR-CD3- . Most
other lymphomas are similar to C2 and D20 (see Table 1) .
The cell surface phenotype of these lymphoma cells was
examined (Fig. 6 and Table 1) . Cells from 21 lymphomas were
Thy-1+TL+L3T4 - Lyt-2-TCR a(3- . Most cells expressed
TCR -y6 and CD3, while a few were negative for TCR y6
and CD3 . The expression of IIr2Ra and HSA was generally
not detected. The tumors were heterogeneous with regard
to the expression of Pgp-1.
The structure and expression ofTCR genes were also ex-
amined and the results are summarized in Table 1 . All except
onelymphoma (A8) had rearranged TCRy and 6 genes and
transcribed y and 6 mRNA of the functional sizes : A8 had
germlineTCRy genes and noy transcripts of the functional
size. No tumor expressed bothTCRa and /3 functional tran-
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DU~t In6re0t aBALE aB6A summary of the results of TCR gene structure in Southern blot analysis with EcoR I, Hind III, BamH I, Xba I and Pvu II digested DNA.
The tumors, which showed a germline configuration with one enzyme, often showed rearranged bands with other enzymes . (G) TCR gene in
germline . (R) TCR gene in clonal rearrangement . Probes used for the analysis are described in Materials and Methods .
t A summary of the results ofTCR transcripts detected in Northern blot analysis. Two different sizes ofmRNAs are identified for each TCRgene .
For all TCRs, the larger mRNAs (1.5 kb for y, 2.0 kb for S, 1.7 kb for a, and 1.3 kb for fl) are the functional transcripts, while smaller mRNAs
(1.2 kb for y, 1.5 kb for 6, 1.3 kb for a, and 1.0 kb for 0) are non-functional aberrant transcripts (34, 36) . Only functional transcripts are scored .
Probes are described in Materials and Methods .
s see Fig . 6 .
II Not done .
scripts simultaneously, althoughsome expressed eitherTCR
a or 0 transcripts of functional sizes. These results corre-
late well with the results offlow cytometry as described above,
although a discrepancy was found with one tumor (El), which
expressed functional y and S mRNA, but was negative for
TCR yb expression . These results of molecular and serolog-
ical analyses indicate that the majority of "lymphocytec
leukemias" of Tg.Tla'-3-1 mice originate fromDN cells be-
longing to theTCR yb lineage, with a few lymphomas arising
from the DN cells before lineage commitment.
Discussion
The present study ofaTL transgenicmouse strain charac-
terized by high levels of TL antigen expression in thymo-
cytes and abnormal thymic development, reveals that thymic
358 yS T Cells in TL Transgenic Mice
T cell differentiation in this strain is deviated almost exclu-
sively toward the yb lineage . Bone marrow transplantation
and thymic graft experiments clearly demonstrate that the
abnormality resides in the stem cells of bone marrow and
not in the thymic environment including the thymic epithe-
lial cells . The most striking event is a sudden disappearance
of small lymphocytes from the thymus between day 14 and
day 21 . This event is distinct from the disappearance of thymo-
cytes induced by stress, irradiation or administration of cor-
tisone. The thymus of TgTla'-3-1 mice shows neither a
"moth-eaten" structure nor the accumulation of macrophages,
eosinophils or necrotic cells in the cortex, which are associated
with the disappearance of thymocytes by these other causes
(40) . The loss ofthymocytes in transgenic mice between day
14 and day 21 is dependent on the genetic background, since
a similar phenomenon occurs but much delayed in (C3H/
Table 1 . Characteristics of Thy-1'TL'L3T4 -Lyt-2- Lymphomas of Tg.T1a°-3-1
TCR gene TCR transcripts Cell surface phenotypes
structure' (functional)*
Tumor TCR TCR
line y S a -y S a yS a0 CD3 HSA Pgp-1
A8 G` R' G - + - - - - - + +
El R R G + + - - - - - - +
C2 R R G + + - - + - + - +
B9 R R G + + - - + - + - +
B1 R R G + + - - + - + - -
D20 R R G + + - - + - + - -
G2 R R G + + - - NDII ND ND ND ND
C5 R R G + + + - ND ND + ND ND
Al R R R + + - - + - + - +
G262 R R R + + - - + - + - -
G3 R R R + + - - + - + - -
A4 R R R + + - - ND ND + ND ND
HA48 R R R + + - - ND ND + ND ND
A2 R R R + + - - ND ND + ND ND
A5 R R R + + - - ND ND + ND ND
A3 R R R + + - - ND ND + ND ND
1311 R R R + + - + + - + - +
D2 R R R + + - + ND ND + ND ND
H5 R R R + + - + ND ND + ND ND
H4 R R R + + - + ND ND + ND ND
G4 R R R + + - + ND ND ND ND NDHe x TgTlaa-3-1), (B6 x TgTlaa-3-1) and (B6Tlaa x
TgTlaa-3-1) Ft mice. The presence ofLyt-2+ SP cells in older
thymus seems not to be essential for the event, because
no Lyt-2+ SP cells are present in the thymus of the bone
marrow chimera mice as shown in Fig. 4 . The gradual in-
crease of large blast-like yb DN thymocytes in older mice
is an another feature of the transgenic thymus . After day 21,
DN thymocytes become the major population and their
differentiation appears to be restricted to ybDN cells. Two
possible mechanisms may account for the disappearance of
thymocytes and proliferation ofybDN thymocytes. One pos-
sibility involves a defect in proliferation and differentiating
capacity of stem cells involved in the development ofT cells,
with an abnormal deviation toward theyb lineage . The other
possibility is the rapid removal of cells belonging to the ctf
lineage including all DP and someDN cells, while leaving
those in theyb lineage intact. Although no visible cell death
was observed in day 14 or day 21 thymus, further study of
this possibility is required, e.g., molecular analysis to detect
DNA fragmentation, a sign of apoptosis, in vitro organ cul-
ture of the thymus, and determination of TCR repertoires
of the ybDN thymocytes . The embryonic thymus of trans-
genic mice is not grossly abnormal, and the growth of the
thymus after birth is close to normal until day 14 . However,
an event occurring during embryonic life may trigger the
abnormal T cell differentiation, and a detailed analysis of
thymic development during embryogenesis isnow under way.
What is the role ofthe transgene in these abnormal events,
and what is the function of TL in normal differentiation?
It is certain that TL expression in the thymus of the trans-
genic mice is not a cause of these events, since conventional
TL' strains and the other transgenic strain, TgTlaa-3-2, do
not show the abnormality. We can not exclude the possi-
bility that the abnormality is a result of insertional activa-
tion or mutagenesis ofgenes unrelated to TL . However, this
genetic alteration has to be under the control of the inserted
TL transgene, since the abnormal phenotype is inherited as
a dominant trait and is restricted to tissues that express the
transgene. These requirements make unrelated insertional
mechanisms unlikely. However, to eliminate this possibility,
over 20 new transgenic mice with various TL and TL chi-
meric genes have been derived and are now being established.
The possibility we feel best explains the results obtained thus
far is that quantitative or qualitative abnormalities inTL ex-
pression in the transgenic mice above a certain threshold cause
abnormal T cell differentiation in the transgenic mice . The
facts are that (a) these mice express over 10 times the level
of TL antigen found in conventional TL' or TgTlaa-3-2
mice, (b) TL is expressed onDN thymocytes which are nega-
tive in conventional TL+ mice, and (c) the abnormality is
restricted to tissues that express TL. Fl mice of (C3H/He
x TgTlaa-3-1), (B6 x TgTlaa-3-1) and (136Th' x TgTlaa-
3-1) crosses show the characteristic abnormalities of Tg.Tla°-
3-1 mice, but the onset of the abnormalities is delayed and
not so pronounced as in parental homozygous TgTlaa-3-1
mice (data not shown) . These results indicate dominant in-
heritance of the abnormality with a gene dosage effect, sug-
gesting that an amplified level of TL expression is causally
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related to abnormal thymic differentiation . If this assump-
tion is correct, one can assume that TL plays"a critical role
in T cell development in the thymus and that thymocytes
ofTL - mice must express otherMHC class I antigens that
are functional equivalents to TL . It has been reported that
someMHC class I genesmapping to the Tla region function
as ligands for yb TCRs (15, 16, 41, 42) . However, unlike
TL genes, these other class I genes are expressed in a variety
of tissues. Recently, the expression ofTL in intestinal epi-
thelium has been described and its relation to yb cells has
been discussed (43, 44) . It remains to be seen whether TL
serves as ligands for certainybTCRs, whether TL is involved
in the selection process ofyb cells, and whether altered ex-
pression ofTL disturbs the normal differentiation ofyb cells .
Much effort has been made to characterize yb cells and
a vast amount ofinformation has been accumulated (15-18) .
However, analysis ofyb cells in the peripheral lymphoid organs
has been difficult because oftheir minor representation (20-22) .
With the advantage of the relative abundance ofyb cells and
-yb T cell lymphomas in TgTlaa-3-1, we have attempted to
stage the maturation ofyb cells. From analysis of surface an-
tigens, the following pathway for ybDN cells is proposed :
the least mature stage 1, IIr2Rac+HSA+Pgp-1+TCR - ;
stage 2, IIr2RocHSA+Pgp-1+TCR- ; stage 3, ID2Ra-
HSA-Pgp-1+TCR yb+ ; and the most mature stage 4, 11,
2RorHSA -Pgp-1 -TCR yb+ . The appearance of surface
TCRyb accompanyingCD3 expression occurs between stage
2 and 3 . This proposed pathway is obviously not complete
andmay not be applicable to all subsets ofyb cells, but this
sequence of changes in the surface phenotype is similar to
that proposed for TCR a(3 lineage (13, 14) . Determination
of the V region usage (45) in theyb thymocytes and T cell
lymphomas should reveal which subsets ofyb cells belong
to this pathway. Immunization using DN cells and T cell
lymphomas from TgTlaa-3-1 mice may produce reagents
specific to the yb lineage and may identify counterparts of
Lyt-2 and L3T4 on yb DN cells .
The immune response of TgTlaa-3-1 mice is severely im-
paired, with T cells being inefficient in helper function for
antibody production, in allogeneicMLC and in ConA stim-
ulation. Since nearly one half of the peripheral T cells in ma-
ture TgTlaa-3-1 mice are ybDN cells, the results strongly
suggest that yb cells cannot participate in or are less active
in theseT cell dependent reactions. Further, the results indi-
cate that the function of cxl cells in these transgenic mice
is also affected, suggesting that only incompetent ao cells
are produced because of the abnormal thymic development .
Alternatively, it is conceivable that the function ofas cells
is suppressed by yb cells in these transgenic mice. The func-
tion of yb cells is largely unknown and their reactivity to
allo-antigens or to mitogens is still unclear. Accordingly, the
use of isolated population ofyb cells from TgTlaa-3-1 mice
in the analysis of other immune functions such as reactivity
to mycobacterial antigens and generation of lymphokines,
should help in dissecting the functions of yb cells and their
relation to the functions of cto cells .
Development ofyb T cell lymphomas is another impor-
tant feature of TgTlaa-3-1 mice. A relatively long latentperiod and clonality ofthese lymphomas clearly indicates that
tumor development requires other genetic events in addition
to the transgene, in a manner similar to lymphomagenesis
in c-mw transgenic mice (46, 47) . Why are Tg.Tla'-3-1 mice
susceptible to lymphomas andwhy do all lymphomas origi-
nate from theyS lineage? An obvious reason for the yS pheno-
type is that the preponderance of thymocytes in older trans-
genic mice are yS cells, while aO cells are a minor population .
There is no evidence to indicate that -yb cells are more sus-
ceptible to lymphomagenesis than cig cells, as there have been
only a few reports on yS T cell lymphomas in mice or in
human (48, 49) . A higher mitotic rate of thymocytes in trans-
References
genic mice than in nontransgenic mice indicates that trans-
genic thymocytes are rapidly dividing, suggesting that one
of the events necessary for the ultimate development of lym-
phomas may have already occurred in these cells. To under-
stand the genetic basis for the sensitivity ofyb cells to lym-
phomagenesis and how this relates to abnormal T cell
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